Primary Recipient

UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON

Amount

$1,096,944.00

Award Date

9/22/2009

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

Argatroban, a thrombin inhibitor, has been studied in the setting of both coronary perfusion as well as acute ischemic stroke. Since the majority of ischemic stroke patients may not benefit from rt-PA alone, the combination of thrombolytics with anticoagu

Recipients Connected to Award

Recipient	Role	Amount
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON	Primary recipient	$741,432.00
UNIVERSITY OF ALABAMA AT BIRMINGHAM	Sub-recipient	$150,705.00
CEDARS-SINAI MEDICAL CENTER	Sub-recipient	$80,096.00
UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER AT DALLAS	Sub-recipient	$69,956.00
ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND, THE	Sub-recipient	$54,755.00